Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RIα subunit: p53-independent mechanism ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-05

AUTHORS

Rakesh K. Srivastava, Aparna R. Srivastava, Prem Seth, Sudhir Agrawal, Yoon S. Cho-Chungi

ABSTRACT

The enhanced expression of the RIα subunit of cyclic AMP-dependent protein kinase type 1 (PKA-I) has been correlated with cancer cell growth. We have investigated the effects of sequence-specific inhibition of RIα gene expression on the growth of MCF-7 human breast cancer cells. We report that RIα antisense treatment results in a reduction in RIα expression at both mRNA and protein levels and inhibition of cell growth. The growth inhibition was accompanied by changes in cell morphology, cleavage of poly(ADP-ribose) polymerase (PARP) and appearance of apoptotic nuclei. In addition, bcl-2 protein level was reduced and p53 expression increased in growth arrested cells. Interestingly, RIα antisense inhibited cell viability and induced apoptosis in the absence of p53, suggesting that these actions of RIα antisense are exerted independent of p53. In contrast, two- and four-base mismatched control oligonucleotides had no effect on either cell growth or morphology. These results demonstrate that the RIα antisense, which efficiently depletes the growth stimulatory molecule RIα, induces cell differentiation and apoptosis, providing a new approach to combat breast cancer cell growth. More... »

PAGES

25-36

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1006990231186

DOI

http://dx.doi.org/10.1023/a:1006990231186

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046249102

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10395066


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Division", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclic AMP-Dependent Protein Kinase RIalpha Subunit", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclic AMP-Dependent Protein Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Down-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Growth Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nucleosomes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oligonucleotides, Antisense", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Poly(ADP-ribose) Polymerases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-bcl-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Up-Regulation", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hybridon Inc., Cambridge, Massachusetts, USA [S.A", 
          "id": "http://www.grid.ac/institutes/grid.452508.e", 
          "name": [
            "Cellular Biochemistry Section, Laboratory of Tumor Immunology and Biology [R. K.S., Y.S. C-C, National Cancer Institute, National Institutes of Health, Bethesda, Maryland and, U.S.A", 
            "Hybridon Inc., Cambridge, Massachusetts, USA [S.A"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Srivastava", 
        "givenName": "Rakesh K.", 
        "id": "sg:person.01155166313.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155166313.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hybridon Inc., Cambridge, Massachusetts, USA [S.A", 
          "id": "http://www.grid.ac/institutes/grid.452508.e", 
          "name": [
            "Cellular Biochemistry Section, Laboratory of Tumor Immunology and Biology [R. K.S., Y.S. C-C, National Cancer Institute, National Institutes of Health, Bethesda, Maryland and, U.S.A", 
            "Hybridon Inc., Cambridge, Massachusetts, USA [S.A"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Srivastava", 
        "givenName": "Aparna R.", 
        "id": "sg:person.01006304074.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006304074.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hybridon Inc., Cambridge, Massachusetts, USA [S.A", 
          "id": "http://www.grid.ac/institutes/grid.452508.e", 
          "name": [
            "Cellular Biochemistry Section, Laboratory of Tumor Immunology and Biology [R. K.S., Y.S. C-C, National Cancer Institute, National Institutes of Health, Bethesda, Maryland and, U.S.A", 
            "Hybridon Inc., Cambridge, Massachusetts, USA [S.A"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seth", 
        "givenName": "Prem", 
        "id": "sg:person.01321376575.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321376575.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hybridon Inc., Cambridge, Massachusetts, USA [S.A", 
          "id": "http://www.grid.ac/institutes/grid.452508.e", 
          "name": [
            "Cellular Biochemistry Section, Laboratory of Tumor Immunology and Biology [R. K.S., Y.S. C-C, National Cancer Institute, National Institutes of Health, Bethesda, Maryland and, U.S.A", 
            "Hybridon Inc., Cambridge, Massachusetts, USA [S.A"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Agrawal", 
        "givenName": "Sudhir", 
        "id": "sg:person.01124454740.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124454740.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hybridon Inc., Cambridge, Massachusetts, USA [S.A", 
          "id": "http://www.grid.ac/institutes/grid.452508.e", 
          "name": [
            "Cellular Biochemistry Section, Laboratory of Tumor Immunology and Biology [R. K.S., Y.S. C-C, National Cancer Institute, National Institutes of Health, Bethesda, Maryland and, U.S.A", 
            "Hybridon Inc., Cambridge, Massachusetts, USA [S.A"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cho-Chungi", 
        "givenName": "Yoon S.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/335440a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037003177", 
          "https://doi.org/10.1038/335440a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0695-528", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004446336", 
          "https://doi.org/10.1038/nm0695-528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/371346a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048646533", 
          "https://doi.org/10.1038/371346a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-05", 
    "datePublishedReg": "1999-05-01", 
    "description": "The enhanced expression of the RI\u03b1 subunit of cyclic AMP-dependent protein kinase type 1 (PKA-I) has been correlated with cancer cell growth. We have investigated the effects of sequence-specific inhibition of RI\u03b1 gene expression on the growth of MCF-7 human breast cancer cells. We report that RI\u03b1 antisense treatment results in a reduction in RI\u03b1 expression at both mRNA and protein levels and inhibition of cell growth. The growth inhibition was accompanied by changes in cell morphology, cleavage of poly(ADP-ribose) polymerase (PARP) and appearance of apoptotic nuclei. In addition, bcl-2 protein level was reduced and p53 expression increased in growth arrested cells. Interestingly, RI\u03b1 antisense inhibited cell viability and induced apoptosis in the absence of p53, suggesting that these actions of RI\u03b1 antisense are exerted independent of p53. In contrast, two- and four-base mismatched control oligonucleotides had no effect on either cell growth or morphology. These results demonstrate that the RI\u03b1 antisense, which efficiently depletes the growth stimulatory molecule RI\u03b1, induces cell differentiation and apoptosis, providing a new approach to combat breast cancer cell growth.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/a:1006990231186", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1016672", 
        "issn": [
          "0300-8177", 
          "1573-4919"
        ], 
        "name": "Molecular and Cellular Biochemistry", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1-2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "195"
      }
    ], 
    "keywords": [
      "sequence-specific inhibition", 
      "antisense", 
      "antisense depletion", 
      "breast cancer cells", 
      "morphology", 
      "cancer cells", 
      "cell viability", 
      "RI\u03b1 subunit", 
      "human breast cancer cells", 
      "cell growth", 
      "cell morphology", 
      "MCF-7 human breast cancer cells", 
      "new approach", 
      "growth", 
      "cells", 
      "cancer cell growth", 
      "cell differentiation", 
      "subunits", 
      "RI\u03b1", 
      "protein levels", 
      "Bcl-2 protein levels", 
      "viability", 
      "absence of p53", 
      "p53-independent mechanism", 
      "induction of apoptosis", 
      "polymerase", 
      "gene expression", 
      "RI\u03b1 expression", 
      "growth arrest", 
      "results", 
      "growth inhibition", 
      "reduction", 
      "breast cancer cell growth", 
      "enhanced expression", 
      "apoptotic nuclei", 
      "addition", 
      "apoptosis", 
      "approach", 
      "expression", 
      "effect", 
      "mismatched control", 
      "p53", 
      "mechanism", 
      "inhibition", 
      "differentiation", 
      "control", 
      "mRNA", 
      "p53 expression", 
      "contrast", 
      "levels", 
      "cleavage", 
      "type 1", 
      "arrest", 
      "induction", 
      "nucleus", 
      "depletion", 
      "absence", 
      "action", 
      "changes", 
      "appearance", 
      "treatment results"
    ], 
    "name": "Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RI\u03b1 subunit: p53-independent mechanism of action", 
    "pagination": "25-36", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046249102"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1006990231186"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10395066"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1006990231186", 
      "https://app.dimensions.ai/details/publication/pub.1046249102"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_343.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/a:1006990231186"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1006990231186'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1006990231186'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1006990231186'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1006990231186'


 

This table displays all metadata directly associated to this object as RDF triples.

230 TRIPLES      21 PREDICATES      107 URIs      96 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1006990231186 schema:about N05e6f96bb5984b6ab7b035e1e71a6301
2 N085927fa939e4a20befc8fd932089d06
3 N258ef3b1492147c2a15a092fd5f43954
4 N3f84a5d819fd42729ad739e4afb8ccfe
5 N41399b6eed5f46719803d46d3df9b921
6 N62f8c281bf6841a4828c78b0852d7135
7 N7835ed8353b94931b78b46ccb3fa8684
8 N80349148503742e9b2cda6403b1a5374
9 N889d1a889ced4c0294f862f8bfc39eb7
10 N88b6461bc6874370a0062255ab9dd6e4
11 Na05093f9c579426ebae9118a24cfd0de
12 Na318973b3e3648469b835f4554a2e33c
13 Na6b5d1e5bcc148499969112d59d3c00f
14 Nb17f207a582b44a48d81573dade476a4
15 Ne2fa1e055ee84a4aa0c1d8f42400fe41
16 Nfa73efdf98b843b19d16c7c87ba19ea1
17 Nfe01a955c1b745f1a58b961b3d801332
18 anzsrc-for:06
19 anzsrc-for:0601
20 schema:author Ncda458ef7ad440669383b19c10a50878
21 schema:citation sg:pub.10.1038/335440a0
22 sg:pub.10.1038/371346a0
23 sg:pub.10.1038/nm0695-528
24 schema:datePublished 1999-05
25 schema:datePublishedReg 1999-05-01
26 schema:description The enhanced expression of the RIα subunit of cyclic AMP-dependent protein kinase type 1 (PKA-I) has been correlated with cancer cell growth. We have investigated the effects of sequence-specific inhibition of RIα gene expression on the growth of MCF-7 human breast cancer cells. We report that RIα antisense treatment results in a reduction in RIα expression at both mRNA and protein levels and inhibition of cell growth. The growth inhibition was accompanied by changes in cell morphology, cleavage of poly(ADP-ribose) polymerase (PARP) and appearance of apoptotic nuclei. In addition, bcl-2 protein level was reduced and p53 expression increased in growth arrested cells. Interestingly, RIα antisense inhibited cell viability and induced apoptosis in the absence of p53, suggesting that these actions of RIα antisense are exerted independent of p53. In contrast, two- and four-base mismatched control oligonucleotides had no effect on either cell growth or morphology. These results demonstrate that the RIα antisense, which efficiently depletes the growth stimulatory molecule RIα, induces cell differentiation and apoptosis, providing a new approach to combat breast cancer cell growth.
27 schema:genre article
28 schema:isAccessibleForFree false
29 schema:isPartOf N48435519d8a349e2b04dcafa27b24f0f
30 Nfe227c373cb64f05a1b445bd80b2cdc9
31 sg:journal.1016672
32 schema:keywords Bcl-2 protein levels
33 MCF-7 human breast cancer cells
34 RIα
35 RIα expression
36 RIα subunit
37 absence
38 absence of p53
39 action
40 addition
41 antisense
42 antisense depletion
43 apoptosis
44 apoptotic nuclei
45 appearance
46 approach
47 arrest
48 breast cancer cell growth
49 breast cancer cells
50 cancer cell growth
51 cancer cells
52 cell differentiation
53 cell growth
54 cell morphology
55 cell viability
56 cells
57 changes
58 cleavage
59 contrast
60 control
61 depletion
62 differentiation
63 effect
64 enhanced expression
65 expression
66 gene expression
67 growth
68 growth arrest
69 growth inhibition
70 human breast cancer cells
71 induction
72 induction of apoptosis
73 inhibition
74 levels
75 mRNA
76 mechanism
77 mismatched control
78 morphology
79 new approach
80 nucleus
81 p53
82 p53 expression
83 p53-independent mechanism
84 polymerase
85 protein levels
86 reduction
87 results
88 sequence-specific inhibition
89 subunits
90 treatment results
91 type 1
92 viability
93 schema:name Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RIα subunit: p53-independent mechanism of action
94 schema:pagination 25-36
95 schema:productId N5b7db6db55844a47b4e02a982c581e0c
96 N781c65b784084535bad3c62c20aba8e2
97 Ne202a4e60e9a4a11ad7b464959d1662d
98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046249102
99 https://doi.org/10.1023/a:1006990231186
100 schema:sdDatePublished 2022-11-24T20:50
101 schema:sdLicense https://scigraph.springernature.com/explorer/license/
102 schema:sdPublisher Nccc7f41077a3442594141a1626ab8987
103 schema:url https://doi.org/10.1023/a:1006990231186
104 sgo:license sg:explorer/license/
105 sgo:sdDataset articles
106 rdf:type schema:ScholarlyArticle
107 N05e6f96bb5984b6ab7b035e1e71a6301 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Down-Regulation
109 rdf:type schema:DefinedTerm
110 N085927fa939e4a20befc8fd932089d06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Breast Neoplasms
112 rdf:type schema:DefinedTerm
113 N258ef3b1492147c2a15a092fd5f43954 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Proto-Oncogene Proteins c-bcl-2
115 rdf:type schema:DefinedTerm
116 N3f84a5d819fd42729ad739e4afb8ccfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Humans
118 rdf:type schema:DefinedTerm
119 N41399b6eed5f46719803d46d3df9b921 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Poly(ADP-ribose) Polymerases
121 rdf:type schema:DefinedTerm
122 N48435519d8a349e2b04dcafa27b24f0f schema:issueNumber 1-2
123 rdf:type schema:PublicationIssue
124 N5b7db6db55844a47b4e02a982c581e0c schema:name doi
125 schema:value 10.1023/a:1006990231186
126 rdf:type schema:PropertyValue
127 N62f8c281bf6841a4828c78b0852d7135 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Up-Regulation
129 rdf:type schema:DefinedTerm
130 N64a39fab6aa84b25ad3a74f4de256931 rdf:first Ncdcc8eee4fb44fc3a4aa5998425e971d
131 rdf:rest rdf:nil
132 N781c65b784084535bad3c62c20aba8e2 schema:name dimensions_id
133 schema:value pub.1046249102
134 rdf:type schema:PropertyValue
135 N7835ed8353b94931b78b46ccb3fa8684 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Cell Survival
137 rdf:type schema:DefinedTerm
138 N7e1fe274327b413290c558308a24510c rdf:first sg:person.01006304074.86
139 rdf:rest N89f88e2945f74b84998264e20da96243
140 N80349148503742e9b2cda6403b1a5374 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Tumor Cells, Cultured
142 rdf:type schema:DefinedTerm
143 N889d1a889ced4c0294f862f8bfc39eb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Apoptosis
145 rdf:type schema:DefinedTerm
146 N88b6461bc6874370a0062255ab9dd6e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Cyclic AMP-Dependent Protein Kinases
148 rdf:type schema:DefinedTerm
149 N89f88e2945f74b84998264e20da96243 rdf:first sg:person.01321376575.25
150 rdf:rest Nf13e644a4d8c4f089e0a693350fb2b37
151 Na05093f9c579426ebae9118a24cfd0de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Nucleosomes
153 rdf:type schema:DefinedTerm
154 Na318973b3e3648469b835f4554a2e33c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Growth Inhibitors
156 rdf:type schema:DefinedTerm
157 Na6b5d1e5bcc148499969112d59d3c00f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Tumor Suppressor Protein p53
159 rdf:type schema:DefinedTerm
160 Nb17f207a582b44a48d81573dade476a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Cyclic AMP-Dependent Protein Kinase RIalpha Subunit
162 rdf:type schema:DefinedTerm
163 Nccc7f41077a3442594141a1626ab8987 schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 Ncda458ef7ad440669383b19c10a50878 rdf:first sg:person.01155166313.46
166 rdf:rest N7e1fe274327b413290c558308a24510c
167 Ncdcc8eee4fb44fc3a4aa5998425e971d schema:affiliation grid-institutes:grid.452508.e
168 schema:familyName Cho-Chungi
169 schema:givenName Yoon S.
170 rdf:type schema:Person
171 Ne202a4e60e9a4a11ad7b464959d1662d schema:name pubmed_id
172 schema:value 10395066
173 rdf:type schema:PropertyValue
174 Ne2fa1e055ee84a4aa0c1d8f42400fe41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Cell Division
176 rdf:type schema:DefinedTerm
177 Nf13e644a4d8c4f089e0a693350fb2b37 rdf:first sg:person.01124454740.04
178 rdf:rest N64a39fab6aa84b25ad3a74f4de256931
179 Nfa73efdf98b843b19d16c7c87ba19ea1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit
181 rdf:type schema:DefinedTerm
182 Nfe01a955c1b745f1a58b961b3d801332 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Oligonucleotides, Antisense
184 rdf:type schema:DefinedTerm
185 Nfe227c373cb64f05a1b445bd80b2cdc9 schema:volumeNumber 195
186 rdf:type schema:PublicationVolume
187 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
188 schema:name Biological Sciences
189 rdf:type schema:DefinedTerm
190 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
191 schema:name Biochemistry and Cell Biology
192 rdf:type schema:DefinedTerm
193 sg:journal.1016672 schema:issn 0300-8177
194 1573-4919
195 schema:name Molecular and Cellular Biochemistry
196 schema:publisher Springer Nature
197 rdf:type schema:Periodical
198 sg:person.01006304074.86 schema:affiliation grid-institutes:grid.452508.e
199 schema:familyName Srivastava
200 schema:givenName Aparna R.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006304074.86
202 rdf:type schema:Person
203 sg:person.01124454740.04 schema:affiliation grid-institutes:grid.452508.e
204 schema:familyName Agrawal
205 schema:givenName Sudhir
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124454740.04
207 rdf:type schema:Person
208 sg:person.01155166313.46 schema:affiliation grid-institutes:grid.452508.e
209 schema:familyName Srivastava
210 schema:givenName Rakesh K.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155166313.46
212 rdf:type schema:Person
213 sg:person.01321376575.25 schema:affiliation grid-institutes:grid.452508.e
214 schema:familyName Seth
215 schema:givenName Prem
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321376575.25
217 rdf:type schema:Person
218 sg:pub.10.1038/335440a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037003177
219 https://doi.org/10.1038/335440a0
220 rdf:type schema:CreativeWork
221 sg:pub.10.1038/371346a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048646533
222 https://doi.org/10.1038/371346a0
223 rdf:type schema:CreativeWork
224 sg:pub.10.1038/nm0695-528 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004446336
225 https://doi.org/10.1038/nm0695-528
226 rdf:type schema:CreativeWork
227 grid-institutes:grid.452508.e schema:alternateName Hybridon Inc., Cambridge, Massachusetts, USA [S.A
228 schema:name Cellular Biochemistry Section, Laboratory of Tumor Immunology and Biology [R. K.S., Y.S. C-C, National Cancer Institute, National Institutes of Health, Bethesda, Maryland and, U.S.A
229 Hybridon Inc., Cambridge, Massachusetts, USA [S.A
230 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...